Trillium Therapeutics Inc.: 25-NSE filed Nov 17, 2021

Form type

25-NSE

Filing date

Nov 17, 2021

Accession number

0001354457-21-001345

Filer

Trillium Therapeutics Inc. (CIK 1616212)